|
|
|
CHI, Philadelphia, PA
March 12-13, 2012
Phase III success rates for the pharmaceutical industry are low, but recent advances in clinical trial design, proof-of- concept, and pre-clinical decision making are set to reduce the attrition rate. Researchers and executives at the inaugural Phase III Clinical Trials conference will be meeting to discuss the latest in regulatory, trial design, phase II to III confidence, success and failure case studies.
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
Invited Speakers:
|
|
Life sciences, pharmaceutical, informatics and IT professionals
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2012-03-06
|
|
|
|
|
|
Registration:
|
|
Online
|
|
E-mail:
|
|
rblack@healthtech.com
|
|
|
|
|
|
|
|